type here...
type here...
START FREE TRIAL

M&A

Technology & AIHealthcareM&AConsumer & RetailEnergyMedia & Entertainment

Is Apple Outflanking Meta With This Q.AI Move?

M&A Ishan Majumdar -
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable silent interaction with devices. The...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

M&A Ishan Majumdar -
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5% on January 22, 2026. The...
spot_imgspot_img

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

Healthcare Ishan Majumdar -
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

APi Group CertaSite Acquisition Sparks Investor Debate

Industrials Ishan Majumdar -
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...

Netflix Warner Bros Acquisition Could Change Streaming Forever

M&A Ishan Majumdar -
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...

Paramount Warner Bros Merger vs. Netflix Explained!

M&A Ishan Majumdar -
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

M&A Ishan Majumdar -
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...

Adobe Acquires Semrush: Game-Changer for Marketers?

M&A Ishan Majumdar -
Adobe just made a bold move that could shift the digital marketing landscape—again. Last week, the company announced a...
Load more

Is Apple Outflanking Meta With This Q.AI Move?

M&A Ishan Majumdar -
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

M&A Ishan Majumdar -
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

Healthcare Ishan Majumdar -
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

APi Group CertaSite Acquisition Sparks Investor Debate

Industrials Ishan Majumdar -
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...

Netflix Warner Bros Acquisition Could Change Streaming Forever

M&A Ishan Majumdar -
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...

Paramount Warner Bros Merger vs. Netflix Explained!

M&A Ishan Majumdar -
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

M&A Ishan Majumdar -
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...

Adobe Acquires Semrush: Game-Changer for Marketers?

M&A Ishan Majumdar -
Adobe just made a bold move that could shift the digital marketing landscape—again. Last week, the company announced a...

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Healthcare Ishan Majumdar -
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Healthcare Ishan Majumdar -
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...

Kimberly Clark’s $48.7B Kenvue Deal: A Power Move or an Expensive Mistake?

M&A Ishan Majumdar -
Kimberly-Clark just made the biggest move in its 150-year history, agreeing to acquire Kenvue—the Johnson & Johnson spin-off and...

Paramount & Skydance’s Bold $70 Billion Gamble: Ellison-Backed Bid For Warner Bros. Discovery

M&A Ishan Majumdar -
Paramount Skydance is preparing to launch one of the most ambitious takeover attempts in Hollywood’s history: a majority cash...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?

0
Pfizer just released mid-stage data from its Metsera-acquired obesity...

Is The Devon + Coterra $21 Billion Merger About Growth — Or Running Out of Rock?

0
Devon Energy just announced a $21.4 billion all-stock acquisition...

Is Apple Outflanking Meta With This Q.AI Move?

0
Apple acquired Israeli startup Q.AI for close to $2B,...

Is Amazon’s $50 Billion OpenAI Deal Really About AI — Or Just AWS Market Share?

0
Amazon is reportedly negotiating a $50 billion investment into...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.